Back to Trials
NCT07415824Recruiting

Multiple Sclerosis Implementation Network (Registry)

The University of Texas Health Science Center, Houston

Start Date

4/28/2025

Completion Date

12/31/2030

Summary

The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life. This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * diagnosed with Multiple Sclerosis * can speak and understand English comfortably

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Multiple Sclerosis

Locations

Multiple Sclerosis Association of America

Cherry Hill, New Jersey 08034

United States

The University of Texas at Austin

Austin, Texas 78712

United States

The University of Texas Health Science Center at Houston (UTHealth Houston)

Houston, Texas 77030

United States